Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Leist

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Interferon Research|June 1, 1986
Antigenic characteristics of glycosylated natural and unglycosylated recombinant human gamma-interferonA Meager, T Leist
Biochemistry|June 5, 1984
Synthesis and physicochemical characterization of major fragments of human leucocyte interferon alpha 1T Leist, R M Thomas
Molecular Immunology|August 1, 1985
Antibodies to synthetic polypeptides corresponding to hydrophilic regions of human interferon gammaT Leist, R Titmas, S Parti, et al.
The Journal of Experimental Medicine|December 1, 1985
Susceptibility to lymphocytic choriomeningitis virus isolates correlates directly with early and high cytotoxic T cell activity, as well as with footpad swelling reaction, and all three are regulated by H-2DR M Zinkernagel, T Leist, H Hengartner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1999
Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: implications for therapy with a monoclonal antibody directed to the IL-2/15R beta receptorN Azimi, S Jacobson, T Leist, et al.
Journal of Neuroimmunology|November 7, 2000
VLA-4/CD49d downregulated on primed T lymphocytes during interferon-beta therapy in multiple sclerosisP A Muraro, T Leist, B Bielekova, et al.
Nature|November 19, 1981
Physicochemical and antigenic properties of synthetic fragments of human leukocyte interferonH Arnheiter, R M Thomas, T Leist, et al.
Medical Microbiology and Immunology|January 1, 1986
Studies on immunity to lymphocytic choriomeningitis virusR M Zinkernagel, T Leist, H Hengartner, et al.
The Journal of Experimental Medicine|July 1, 1989
Major histocompatibility complex-linked susceptibility or resistance to disease caused by a noncytopathic virus varies with the disease parameter evaluatedT Leist, A Althage, E Haenseler, et al.
The Journal of Experimental Medicine|October 1, 1986
T cell-mediated hepatitis in mice infected with lymphocytic choriomeningitis virus. Liver cell destruction by H-2 class I-restricted virus-specific cytotoxic T cells as a physiological correlate of the 51Cr-release assay?R M Zinkernagel, E Haenseler, T Leist, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Interferon Research|June 1, 1986
Antigenic characteristics of glycosylated natural and unglycosylated recombinant human gamma-interferonA Meager, T Leist
Biochemistry|June 5, 1984
Synthesis and physicochemical characterization of major fragments of human leucocyte interferon alpha 1T Leist, R M Thomas
Molecular Immunology|August 1, 1985
Antibodies to synthetic polypeptides corresponding to hydrophilic regions of human interferon gammaT Leist, R Titmas, S Parti, et al.
The Journal of Experimental Medicine|December 1, 1985
Susceptibility to lymphocytic choriomeningitis virus isolates correlates directly with early and high cytotoxic T cell activity, as well as with footpad swelling reaction, and all three are regulated by H-2DR M Zinkernagel, T Leist, H Hengartner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1999
Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: implications for therapy with a monoclonal antibody directed to the IL-2/15R beta receptorN Azimi, S Jacobson, T Leist, et al.
Journal of Neuroimmunology|November 7, 2000
VLA-4/CD49d downregulated on primed T lymphocytes during interferon-beta therapy in multiple sclerosisP A Muraro, T Leist, B Bielekova, et al.
Nature|November 19, 1981
Physicochemical and antigenic properties of synthetic fragments of human leukocyte interferonH Arnheiter, R M Thomas, T Leist, et al.
Medical Microbiology and Immunology|January 1, 1986
Studies on immunity to lymphocytic choriomeningitis virusR M Zinkernagel, T Leist, H Hengartner, et al.
The Journal of Experimental Medicine|July 1, 1989
Major histocompatibility complex-linked susceptibility or resistance to disease caused by a noncytopathic virus varies with the disease parameter evaluatedT Leist, A Althage, E Haenseler, et al.
The Journal of Experimental Medicine|October 1, 1986
T cell-mediated hepatitis in mice infected with lymphocytic choriomeningitis virus. Liver cell destruction by H-2 class I-restricted virus-specific cytotoxic T cells as a physiological correlate of the 51Cr-release assay?R M Zinkernagel, E Haenseler, T Leist, et al.
Pageof 2